首页 > 市场调查报告书 > 製药

再生医学细胞疗法

干细胞市场规模、份额和成长分析（按治疗方法、细胞类型、应用、技术、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1904842

干细胞市场规模、份额和成长分析（按治疗方法、细胞类型、应用、技术、最终用户和地区划分）—2026-2033年产业预测

Stem Cell Market Size, Share, and Growth Analysis, By Therapy Type (Allogeneic, Autologous), By Cell Type, By Application, By Technology, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 275 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球干细胞市场规模将达到 148.2 亿美元，到 2025 年将达到 165.1 亿美元，到 2033 年将达到 391.5 亿美元，在预测期（2026-2033 年）内，复合年增长率为 11.4%。

全球干细胞市场正经历显着成长，这主要得益于临床试验数量的增加和干细胞疗法的日益普及。研究活动的激增，尤其是在应对医疗挑战方面，正为间质干细胞疗法等创新应用铺平道路，这些疗法可用于治疗多种疾病。人们对脐带干细胞益处的认识不断提高，以及对再生医学的强劲需求，正在推动该领域的投资。儘管政府资助在开发慢性病创新治疗方法继续发挥关键作用，但高成本和复杂的监管等挑战仍然存在。儘管存在这些障碍，但整体前景仍然乐观，因为研发投入和主要参与者之间的合作有望进一步扩大市场潜力并改善患者的治疗效果。

全球干细胞市场驱动因素

癌症、糖尿病和心血管疾病等慢性疾病发病率的不断上升，显着推动了干细胞疗法的需求成长。干细胞移植、输注疗法以及各种以干细胞为基础的介入措施等治疗方法，作为应对这些健康挑战的有效方案，正日益受到欢迎。尤其值得一提的是，干细胞疗法作为一种非手术方法，在缓解骨关节炎引起的膝关节疼痛方面获得了广泛认可。随着越来越多的患者和医疗服务提供者寻求先进且有效的治疗方案，对这些创新治疗方法的需求不断增长，也凸显了推动全球干细胞市场扩张的更广泛趋势。

限制全球干细胞市场的因素

影响全球干细胞市场的主要限制因素是干细胞疗法（包括移植、注射和各种治疗）的高成本。这一经济障碍阻碍了这些先进治疗方法的广泛应用和普及，尤其是在经济资源有限的发展中地区。因此，许多患者无力负担这些治疗费用，直接限制了市场的整体成长潜力。缺乏负担得起的干细胞疗法加剧了医疗保健方面的不平等，阻碍了该领域的进步，并最终使患者无法充分受益于干细胞创新。

全球干细胞市场趋势

全球干细胞市场正经历着向个人化医疗的显着转变，治疗方法正朝着更个人化的方向发展，以满足每位患者的个别特征。干细胞研究和技术的进步使得根据患者独特的基因组成和病历定制治疗方案成为可能。这种个人化不仅提高了治疗效果，还有助于改善患者的预后，从而推动了包括关节疾病在内的各个医学领域对个人化治疗的需求。随着医疗保健行业不断优先考虑以患者为中心的解决方案，对个人化干细胞疗法的关注预计将会扩大，从而塑造再生医学的未来并推动市场成长。

北美（按治疗方法、细胞类型、应用、技术和最终用户划分）
- 美国
- 加拿大
欧洲（依治疗方法、细胞类型、应用、技术、最终用户划分）
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
亚太地区（按治疗方法、细胞类型、应用、技术和最终用户划分）
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲（按治疗方法、细胞类型、应用、技术、最终用户划分）
- 巴西
- 墨西哥
- 其他拉丁美洲地区
中东和非洲（按治疗方法、细胞类型、应用、技术和最终用户划分）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争对手仪錶板

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）

主要企业简介

Thermo Fisher Scientific, Inc.
The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
Mesoblast Ltd
CRISPR Therapeutics
Merck KGaA
Lonza Group
Becton Dickinson（BD）
Sartorius AG
Miltenyi Biotec
Bio-Rad Laboratories
Bio-Techne
Eppendorf AG
Corning Inc.
Takara Bio Inc.
Fujifilm Cellular Dynamics
Stemcell Technologies
American CryoStem Corporation
CellGenix GmbH
Medipost
Holostem Terapie Avanzate
Catalent Inc.

结论与建议

简介目录

Product Code: SQMIG35D2059

Global Stem Cell Market size was valued at USD 14.82 Billion in 2024 and is poised to grow from USD 16.51 Billion in 2025 to USD 39.15 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The global stem cell market is witnessing significant growth, fueled by increasing clinical trials and the wider adoption of stem cell therapies. The surge in research initiatives, particularly in response to healthcare challenges, is paving the way for innovative applications, such as mesenchymal stem cell therapies for various conditions. Enhanced awareness regarding the advantages of umbilical stem cells and strong demand for regenerative treatments are driving investments in the sector. While government funding continues to play a crucial role in advancing innovative treatments for chronic diseases, challenges such as high costs and regulatory complexities persist. Despite these obstacles, the overall landscape remains promising, as research and development efforts, along with collaboration among key players, are set to further expand the market's potential and improve patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Market Segments Analysis

Global Stem Cell Market is segmented by Therapy Type, Cell Type, Application, Technology, End-User and region. Based on Therapy Type, the market is segmented into Allogeneic and Autologous. Based on Cell Type, the market is segmented into Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (IPSCs) and Very Small Embryonic-Like Stem Cells (VSELs). Based on Application, the market is segmented into Regenerative Medicine, Drug Discovery & Development and Clinical Research. Based on Technology, the market is segmented into Cell Acquisition, Cell Production, Cryopreservation and Expansion and Sub-Culture. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Market

The growing incidence of chronic illnesses, including cancer, diabetes, and cardiovascular conditions, is significantly boosting the demand for stem cell therapies. Treatments such as stem cell transplants, injections, and various stem cell-based interventions are becoming more prevalent as viable solutions for these health challenges. Notably, stem cell therapy has emerged as a popular non-surgical approach for alleviating knee pain associated with osteoarthritis. This escalating demand for innovative therapeutic options underscores a broader trend that is poised to propel the expansion of the global stem cell market, as more patients and healthcare providers seek advanced and effective treatment alternatives.

Restraints in the Global Stem Cell Market

A significant constraint affecting the global stem cell market is the elevated cost tied to stem cell therapies, encompassing procedures such as transplants, injections, and various treatments. This financial barrier hampers the widespread acceptance and utilization of these advanced therapies, especially in developing regions where economic resources are limited. As a result, numerous patients find these options financially unattainable, which directly constrains the overall growth potential of the market. The inability to access affordable stem cell treatments perpetuates healthcare disparities and inhibits advancements within the sector, ultimately hindering the realization of the full benefits of stem cell innovations.

Market Trends of the Global Stem Cell Market

The global stem cell market is witnessing a notable shift towards personalized medicine, as therapies evolve to cater to individual patient profiles. Advancements in stem cell research and technology are facilitating the creation of tailored treatments that align with a patient's unique genetic composition and medical history. This customization not only enhances treatment efficacy but also improves patient outcomes, driving demand for individualized therapies across various medical conditions, including joint issues. As healthcare continues to prioritize patient-centric solutions, the focus on personalized stem cell therapies is poised to expand, shaping the future of regenerative medicine and augmenting market growth.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impact Factor
Top Investment Pockets
Market Attractiveness Index
Market Ecosystem
PESTEL Analysis
Regulatory Landscape
Case Study Analysis
Value Chain Analysis
Patent Analysis
Technology Analysis
Clinical Trial Analysis
Disease Epidemiology

Global Stem Cell Market Size by Therapy Type (2019-2032)

Market Overview
Allogeneic
Autologous

Global Stem Cell Market Size by Cell Type (2019-2032)

Market Overview
Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Epithelial/Skin
- Other ASCs
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (IPSCs)
Very Small Embryonic-Like Stem Cells (VSELs)

Global Stem Cell Market Size by Application (2019-2032)

Market Overview
Regenerative Medicine
- Neurology
- Orthopaedics
- Musculoskeletal Disorders
- Oncology
- Haematology
- Cardiovascular
- Metabolic Disorders
- Liver Disorders
- Incontinence
- Other Regenerative Medicines
Drug Discovery & Development
Clinical Research

Global Stem Cell Market Size by Technology (2019-2032)

Market Overview
Cell Acquisition
- Bone Marrow Harvest
- Umbilical Cord Blood
- Apheresis
Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
Cryopreservation
Expansion and Sub-Culture

Global Stem Cell Market Size by End-User (2019-2032)

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes
Others

Global Stem Cell Market Size (2019-2032)

North America (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- US
- Canada
Europe (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Dashboard

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025

Key Company Profiles

Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio Overview
- Financial Overview
- Key Developments
The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
Mesoblast Ltd
CRISPR Therapeutics
Merck KGaA
Lonza Group
Becton Dickinson (BD)
Sartorius AG
Miltenyi Biotec
Bio-Rad Laboratories
Bio-Techne
Eppendorf AG
Corning Inc.
Takara Bio Inc.
Fujifilm Cellular Dynamics
Stemcell Technologies
American CryoStem Corporation
CellGenix GmbH
Medipost
Holostem Terapie Avanzate
Catalent Inc.